Cardlytics
CDLX
164 hedge funds and large institutions have $1.87B invested in Cardlytics in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 65 increasing their positions, 52 reducing their positions, and 26 closing their positions.
117% more call options, than puts
Call options by funds: $13M | Put options by funds: $6.01M
25% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 52
7% more capital invested
Capital invested by funds: $1.75B → $1.87B (+$122M)
0.48% more ownership
Funds ownership: 9.28% → 9.76% (+0.48%)
0% more funds holding
Funds holding: 164 → 164 (0)
0% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 26
9% less funds holding in top 10
Funds holding in top 10: 11 → 10 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
CAS Investment Partners
Westport,
Connecticut
|
+$27.4M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$19.8M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$18.5M |
| 4 |
BlackRock
New York
|
+$16M |
| 5 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$14.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tybourne Capital Management
Hong Kong
|
-$51.6M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$22.1M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$8.61M |
| 4 |
BCM
Bienville Capital Management
New York
|
-$7.26M |
| 5 |
CCM
Clearfield Capital Management
New York
|
-$7.25M |
CDLX Hedge Fund Activity: Q3 2020 in Review
164 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q3 2020, worth a combined $1.87B — up 7% from $1.75B a quarter earlier.
Fund positioning in CDLX was balanced in Q3 2020: 26 funds opened new positions, 26 closed out, 65 added to existing stakes and 52 trimmed.
The largest buyer was CAS Investment Partners, adding an estimated $27.4M. The largest seller was Tybourne Capital Management, exiting entirely with an estimated $51.6M sold.
- 164 institutional investors held Cardlytics (CDLX) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $1.87B of Cardlytics stock for Q3 2020, up 7% quarter-over-quarter.
- 26 funds opened new Cardlytics positions in Q3 2020 and 26 closed out, a net change of 0 holders.
- The largest Cardlytics buyer in Q3 2020 was CAS Investment Partners, an estimated $27.4M added.
- The largest Cardlytics seller in Q3 2020 was Tybourne Capital Management, an estimated $51.6M sold.
Based on aggregated 13F filings for Q3 2020.